Life sciences
Royal London and XLB advance second phase of Cambridge R&D scheme
The 90,411 sq ft development comprises 11 units designed for technology and scientific occupiers
Pension fund buys Oxford business park for life sciences play
Buyer steps in after private equity firm fails to progress deal
Q+A: Knight Frank Berlin – "Deals will start to go again in the fourth quarter"
Managing partner Hanns-Joachim Fredrich tells React News how broker competition can contribute to the failure of a deal
Urgent 100,000 sq ft biolab requirement launches
Mystery search focused on facilities capable of complying with high biosafety levels
German bioscience firm moves into Portsmouth
Letting follows the government’s £60m pledge to expand life sciences manufacturing in the UK
Joining the rush to invest in Oxford? Time to do your homework
Life sciences boom masks other unique opportunities
Biotech firm signs 10-year lease at Cambridge’s Mortlock House
Lateral agrees letting shortly after buying the building with Amazon Capital
Cambridge Science Park appoints new director
Trinity College-owned park is currently one of the UK's most desirable investment destinations